| (E)-roxithromycin | increases expression | ISO | RGD:1606342 | 6480464 | Roxithromycin results in increased expression of FASLG protein | CTD | PMID:12921874 |
| (R)-adrenaline | multiple interactions | ISO | RGD:1606342 | 6480464 | Atenolol inhibits the reaction [Epinephrine results in increased expression of FASLG protein]; more ... | CTD | PMID:10728402 |
| (R)-adrenaline | increases expression | ISO | RGD:1606342 | 6480464 | Epinephrine results in increased expression of FASLG protein | CTD | PMID:10728402 |
| (S)-nicotine | increases expression | ISO | RGD:1606342 | 6480464 | Nicotine results in increased expression of FASLG mRNA | CTD | PMID:19896492 more ... |
| (S)-nicotine | increases expression | ISO | RGD:1606342 | 6480464 | Nicotine results in increased expression of FASLG mRNA | CTD | PMID:20383341 more ... |
| (S)-nicotine | increases expression | ISO | RGD:1606342 | 6480464 | Nicotine results in increased expression of FASLG mRNA | CTD | PMID:18247414 more ... |
| (S)-nicotine | increases expression | ISO | RGD:1606342 | 6480464 | Nicotine results in increased expression of FASLG mRNA | CTD | PMID:20383341 more ... |
| (S)-nicotine | increases expression | EXP | | 6480464 | Nicotine results in increased expression of FASLG protein alternative form | CTD | PMID:18203686 |
| (S)-nicotine | affects expression | EXP | | 6480464 | Nicotine affects the expression of FASLG mRNA | CTD | PMID:20426880 |
| (S)-nicotine | increases expression | ISO | RGD:1606342 | 6480464 | Nicotine results in increased expression of FASLG protein | CTD | PMID:20383341 |
| 17beta-estradiol | multiple interactions | ISO | RGD:1606342 | 6480464 | Tamoxifen inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin co-treated with Estradiol] results in decreased expression of FASLG mRNA]; more ... | CTD | PMID:20529085 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases response to substance | ISO | RGD:1553064 | 6480464 | FASL protein results in increased susceptibility to Tetrachlorodibenzodioxin | CTD | PMID:11551431 PMID:10527913 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1553064 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of FASL mRNA | CTD | PMID:10527913 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1553064 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of FASL protein | CTD | PMID:15972635 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1553064 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of FASL mRNA | CTD | PMID:18334599 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1553064 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of FASL protein | CTD | PMID:15972635 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1553064 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of FASL mRNA | CTD | PMID:15972635 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1553064 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of FASL protein | CTD | PMID:10527913 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1553064 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of FASL mRNA | CTD | PMID:15972635 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1553064 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of FASL mRNA | CTD | PMID:15310856 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1553064 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of FASL protein | CTD | PMID:10527913 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases response to substance | ISO | RGD:1553064 | 6480464 | FASL protein results in increased susceptibility to Tetrachlorodibenzodioxin | CTD | PMID:10527913 PMID:11551431 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1553064 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of FASL protein | CTD | PMID:15664267 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1553064 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of FASL mRNA | CTD | PMID:15664267 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of FASLG mRNA | CTD | PMID:19520675 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1606342 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of FASLG mRNA | CTD | PMID:11007951 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1606342 | 6480464 | Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of FASLG mRNA] | CTD | PMID:11007951 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1553064 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of FASL protein | CTD | PMID:15664267 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1553064 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of FASL mRNA | CTD | PMID:12167310 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1553064 | 6480464 | [Tetrachlorodibenzodioxin results in increased expression of AHR mRNA] which results in increased expression of FASL mRNA | CTD | PMID:18334599 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1553064 | 6480464 | NFKB1 protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of FASL protein]; more ... | CTD | PMID:15972635 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1553064 | 6480464 | AHR protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of FASL mRNA]; more ... | CTD | PMID:16940415 |
| 2,4,6-trinitrobenzenesulfonic acid | multiple interactions | ISO | RGD:1553064 | 6480464 | D-JNKI-1 inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of FASL protein] | CTD | PMID:22427801 |
| 2,4,6-trinitrobenzenesulfonic acid | increases expression | ISO | RGD:1553064 | 6480464 | Trinitrobenzenesulfonic Acid results in increased expression of FASL protein | CTD | PMID:22427801 |
| 2,6-dichloroindophenol | multiple interactions | ISO | RGD:1606342 | 6480464 | [2,6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in increased expression of FASLG mRNA | CTD | PMID:21034357 |
| 2-naphthylamine | decreases expression | ISO | RGD:1606342 | 6480464 | 2-Naphthylamine results in decreased expression of FASLG mRNA | CTD | PMID:18247414 |
| 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine | increases expression | EXP | | 6480464 | Puromycin Aminonucleoside results in increased expression of FASL protein | CTD | PMID:16152783 |
| 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine | multiple interactions | EXP | | 6480464 | Melatonin inhibits the reaction [Puromycin Aminonucleoside results in increased expression of FASLG protein] | CTD | PMID:14993511 |
| 4'-epidoxorubicin | increases expression | EXP | | 6480464 | Epirubicin results in increased expression of FASLG protein; more ... | CTD | PMID:19429229 |
| 4,4'-diaminodiphenylmethane | increases expression | ISO | RGD:1553064 | 6480464 | 4,4'-diaminodiphenylmethane results in increased expression of FASL mRNA | CTD | PMID:18648102 |
| 4-hydroperoxycyclophosphamide | increases expression | ISO | RGD:1606342 | 6480464 | perfosfamide results in increased expression of FASLG mRNA; more ... | CTD | PMID:14760101 |
| 5-azacytidine | increases response to substance | ISO | RGD:1553064 | 6480464 | Azacitidine results in increased susceptibility to FASLG protein | CTD | PMID:18829727 |
| 5-azacytidine | increases response to substance | ISO | RGD:1606342 | 6480464 | Azacitidine results in increased susceptibility to FASLG protein | CTD | PMID:18829727 |
| 5-fluorouracil | increases response to substance | ISO | RGD:1553064 | 6480464 | FASL results in increased susceptibility to Fluorouracil | CTD | PMID:11196169 |
| 5-fluorouracil | increases expression | ISO | RGD:1553064 | 6480464 | Fluorouracil results in increased expression of FASL | CTD | PMID:11196169 |
| 8-bromo-3',5'-cyclic AMP | multiple interactions | ISO | RGD:1606342 | 6480464 | [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of FASLG protein | CTD | PMID:16709600 |
| acetylsalicylic acid | multiple interactions | EXP | | 6480464 | Aspirin inhibits the reaction [Azoxymethane results in increased expression of FASLG mRNA] | CTD | PMID:20043115 |
| adenosine | increases expression | ISO | RGD:1606342 | 6480464 | Adenosine results in increased expression of FASLG protein | CTD | PMID:16419169 |
| aldosterone | increases expression | EXP | | 6480464 | Aldosterone results in increased expression of FASLG protein | CTD | PMID:19001025 |
| all-trans-acitretin | increases expression | ISO | RGD:1606342 | 6480464 | Acitretin results in increased expression of FASLG | CTD | PMID:18624760 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:1606342 | 6480464 | [Clozapine co-treated with Hydrogen Peroxide co-treated with Tretinoin] results in increased expression of FASLG mRNA | CTD | PMID:16510162 |
| all-trans-retinoic acid | decreases expression | ISO | RGD:1606342 | 6480464 | Tretinoin results in decreased expression of FASLG protein; more ... | CTD | PMID:16957513 |
| aluminium trichloride | increases expression | EXP | | 6480464 | aluminum chloride results in increased expression of FASLG mRNA | CTD | PMID:23065425 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of FASLG mRNA | CTD | PMID:16483693 |
| arachidonic acid | multiple interactions | ISO | RGD:1606342 | 6480464 | Acetylcysteine inhibits the reaction [Arachidonic Acid results in increased expression of FASLG protein]; more ... | CTD | PMID:19720122 |
| arachidonic acid | increases expression | ISO | RGD:1606342 | 6480464 | Arachidonic Acid results in increased expression of FASLG protein; more ... | CTD | PMID:19720122 |
| arsenic atom | decreases expression | ISO | RGD:1606342 | 6480464 | Arsenic results in decreased expression of FASLG mRNA | CTD | PMID:11134558 PMID:19962721 |
| arsenic atom | multiple interactions | ISO | RGD:1606342 | 6480464 | [Arsenic co-treated with Fluorides] results in decreased expression of FASLG mRNA | CTD | PMID:19962721 |
| arsenic atom | decreases expression | ISO | RGD:1606342 | 6480464 | Arsenic results in decreased expression of FASLG mRNA | CTD | PMID:19962721 PMID:11134558 |
| atenolol | multiple interactions | ISO | RGD:1606342 | 6480464 | Atenolol inhibits the reaction [Epinephrine results in increased expression of FASLG protein] | CTD | PMID:10728402 |
| bafilomycin A1 | multiple interactions | ISO | RGD:1553064 | 6480464 | bafilomycin A1 inhibits the reaction [FASL protein affects the localization of Calcium] | CTD | PMID:20200208 |
| benazepril | multiple interactions | EXP | | 6480464 | benazepril inhibits the reaction [Doxorubicin results in increased expression of FASLG protein]; more ... | CTD | PMID:15315341 |
| benzo[a]pyrene | increases expression | ISO | RGD:1606342 | 6480464 | Benzo(a)pyrene results in increased expression of FASLG protein | CTD | PMID:16041517 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:1606342 | 6480464 | AHR mutant form inhibits the reaction [Benzo(a)pyrene promotes the reaction [FASLG protein results in increased cleavage of CASP8 protein]]; more ... | CTD | PMID:22951985 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:1606342 | 6480464 | Nitrogen Oxides inhibits the reaction [Benzo(a)pyrene results in increased expression of FASLG protein] | CTD | PMID:16041517 |
| benzo[a]pyrene | increases expression | ISO | RGD:1606342 | 6480464 | Benzo(a)pyrene results in increased expression of FASLG mRNA | CTD | PMID:18247414 |
| berberine | increases expression | ISO | RGD:1606342 | 6480464 | Berberine results in increased expression of FASLG mRNA; more ... | CTD | PMID:20656010 |
| beta-hexachlorocyclohexane | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [beta-hexachlorocyclohexane results in increased expression of FASLG protein] | CTD | PMID:19760616 |
| beta-hexachlorocyclohexane | increases expression | EXP | | 6480464 | beta-hexachlorocyclohexane results in increased expression of FASLG protein | CTD | PMID:19760616 |
| bezafibrate | affects expression | ISO | RGD:1606342 | 6480464 | Bezafibrate affects the expression of FASLG protein modified form | CTD | PMID:15063428 |
| bis(2-chloroethyl) sulfide | multiple interactions | ISO | RGD:1606342 | 6480464 | IL10 protein affects the reaction [Mustard Gas affects the expression of FASLG mRNA]; more ... | CTD | PMID:16173061 |
| bis(2-chloroethyl) sulfide | increases expression | ISO | RGD:1606342 | 6480464 | Mustard Gas results in increased expression of FASLG protein | CTD | PMID:12482751 |
| bis(2-chloroethyl) sulfide | increases expression | ISO | RGD:1606342 | 6480464 | Mustard Gas results in increased expression of FASLG mRNA | CTD | PMID:16173061 |
| bisphenol A | increases expression | ISO | RGD:1553064 | 6480464 | bisphenol A results in increased expression of FASL protein | CTD | PMID:19193734 |
| bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of FASLG mRNA | CTD | PMID:19267065 |
| bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of FASLG mRNA | CTD | PMID:19267065 |
| bleomycin A2 | increases expression | ISO | RGD:1553064 | 6480464 | Bleomycin results in increased expression of FASLG mRNA | CTD | PMID:11350791 |
| busulfan | decreases expression | ISO | RGD:1553064 | 6480464 | Busulfan results in decreased expression of FASL mRNA | CTD | PMID:15388331 |
| cadmium dichloride | increases expression | ISO | RGD:1553064 | 6480464 | Cadmium Chloride results in increased expression of FASL protein | CTD | PMID:21620867 |
| cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of FASLG protein | CTD | PMID:21819444 |
| cadmium dichloride | multiple interactions | EXP | | 6480464 | telmisartan inhibits the reaction [Cadmium Chloride results in increased expression of FASLG protein] | CTD | PMID:21819444 |
| cadmium dichloride | multiple interactions | ISO | RGD:1553064 | 6480464 | telmisartan inhibits the reaction [Cadmium Chloride results in increased expression of FASL protein] | CTD | PMID:21620867 |
| calcitriol | decreases expression | EXP | | 6480464 | Calcitriol results in decreased expression of FASLG protein | CTD | PMID:17570329 |
| calcium atom | multiple interactions | ISO | RGD:1553064 | 6480464 | CD38 gene mutant form inhibits the reaction [FASL protein affects the localization of Calcium]; more ... | CTD | PMID:20200208 |
| calcium atom | affects localization | ISO | RGD:1553064 | 6480464 | FASL protein affects the localization of Calcium | CTD | PMID:20200208 |
| calcium(0) | multiple interactions | ISO | RGD:1553064 | 6480464 | CD38 gene mutant form inhibits the reaction [FASL protein affects the localization of Calcium]; more ... | CTD | PMID:20200208 |
| calcium(0) | affects localization | ISO | RGD:1553064 | 6480464 | FASL protein affects the localization of Calcium | CTD | PMID:20200208 |
| candesartan | multiple interactions | EXP | | 6480464 | candesartan inhibits the reaction [Daunorubicin results in increased expression of FASLG protein] | CTD | PMID:16324756 |
| capsaicin | multiple interactions | EXP | | 6480464 | Naproxen inhibits the reaction [Capsaicin results in increased expression of FASLG protein]; more ... | CTD | PMID:22150557 |
| capsaicin | increases expression | EXP | | 6480464 | Capsaicin results in increased expression of FASLG protein | CTD | PMID:22150557 |
| carbachol | multiple interactions | ISO | RGD:1606342 | 6480464 | [Carbachol results in increased activity of CHRM1 protein] which results in increased expression of FASLG protein; more ... | CTD | PMID:8683117 |
| carbamazepine | increases expression | ISO | RGD:1553064 | 6480464 | Carbamazepine results in increased expression of FASL mRNA | CTD | PMID:22790970 |
| carbon disulfide | increases expression | EXP | | 6480464 | Carbon Disulfide results in increased expression of FASLG mRNA | CTD | PMID:17241545 |
| carvedilol | multiple interactions | ISO | RGD:1606342 | 6480464 | carvedilol inhibits the reaction [Epinephrine results in increased expression of FASLG protein] | CTD | PMID:10728402 |
| celastrol | increases expression | ISO | RGD:1606342 | 6480464 | tripterine results in increased expression of FASLG protein | CTD | PMID:21466843 |
| chloramphenicol | decreases expression | ISO | RGD:1553064 | 6480464 | Chloramphenicol results in decreased expression of FASLG | CTD | PMID:18559535 |
| cholesterol | increases expression | EXP | | 6480464 | Cholesterol analog results in increased expression of FASLG protein | CTD | PMID:19477266 |
| chrysazin | increases expression | ISO | RGD:1606342 | 6480464 | danthron results in increased expression of FASLG protein | CTD | PMID:21126053 |
| cisplatin | multiple interactions | ISO | RGD:1606342 | 6480464 | Acetylcysteine inhibits the reaction [[Cisplatin co-treated with FASLG protein] results in decreased expression of BID protein]; more ... | CTD | PMID:17574045 |
| cisplatin | increases expression | ISO | RGD:1606342 | 6480464 | Cisplatin results in increased expression of FASLG mRNA | CTD | PMID:20878077 PMID:16957513 |
| cisplatin | increases expression | ISO | RGD:1606342 | 6480464 | Cisplatin results in increased expression of FASLG protein | CTD | PMID:16957513 PMID:21216935 |
| cisplatin | multiple interactions | EXP | | 6480464 | 1,3-dimethylthiourea inhibits the reaction [Cisplatin results in increased expression of FASLG mRNA] | CTD | PMID:12684229 |
| cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of FASLG mRNA | CTD | PMID:12684229 |
| cisplatin | multiple interactions | ISO | RGD:1606342 | 6480464 | [nutlin 3 promotes the reaction [FAS protein binds to FASLG protein]] which results in increased susceptibility to Cisplatin | CTD | PMID:21509038 |
| cisplatin | multiple interactions | ISO | RGD:1606342 | 6480464 | Y 27632 inhibits the reaction [Cisplatin results in increased expression of FASLG mRNA] | CTD | PMID:20878077 |
| cisplatin | increases expression | ISO | RGD:1606342 | 6480464 | Cisplatin results in increased expression of FASLG protein | CTD | PMID:21216935 PMID:16957513 |
| cisplatin | increases expression | ISO | RGD:1606342 | 6480464 | Cisplatin results in increased expression of FASLG mRNA | CTD | PMID:16957513 PMID:20878077 |
| cisplatin | multiple interactions | ISO | RGD:1606342 | 6480464 | [Cisplatin co-treated with fisetin] results in increased expression of FASLG protein | CTD | PMID:21216935 |
| cisplatin | multiple interactions | ISO | RGD:1553064 | 6480464 | [Cisplatin co-treated with vinorelbine] results in decreased expression of FASL mRNA | CTD | PMID:21544650 |
| clozapine | multiple interactions | ISO | RGD:1606342 | 6480464 | [Clozapine co-treated with Hydrogen Peroxide co-treated with Tretinoin] results in increased expression of FASLG mRNA; more ... | CTD | PMID:16510162 |
| cobalt atom | increases expression | ISO | RGD:1553064 | 6480464 | Cobalt results in increased expression of FASL mRNA | CTD | PMID:22147119 |
| cobalt atom | increases expression | ISO | RGD:1606342 | 6480464 | Cobalt results in increased expression of FASL mRNA | CTD | PMID:18078969 |
| cobalt atom | multiple interactions | ISO | RGD:1606342 | 6480464 | [tungsten carbide co-treated with Cobalt] results in increased expression of FASL mRNA | CTD | PMID:18078969 |
| cobalt dichloride | decreases expression | ISO | RGD:1606342 | 6480464 | cobaltous chloride results in decreased expression of FASLG mRNA | CTD | PMID:17553155 |
| cobalt dichloride | increases expression | ISO | RGD:1606342 | 6480464 | cobaltous chloride results in increased expression of FASL mRNA | CTD | PMID:18078969 |
| curcumin | multiple interactions | ISO | RGD:1606342 | 6480464 | Curcumin inhibits the reaction [[vorinostat co-treated with bortezomib] results in increased expression of FASLG protein] | CTD | PMID:17351739 |
| curcumin | decreases expression | ISO | RGD:1606342 | 6480464 | Curcumin results in decreased expression of FASLG mRNA | CTD | PMID:16101141 |
| curcumin | decreases expression | EXP | | 6480464 | Curcumin results in decreased expression of FASLG mRNA | CTD | PMID:10925121 |
| cycloheximide | multiple interactions | ISO | RGD:1606342 | 6480464 | Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of FASLG mRNA] | CTD | PMID:11007951 |
| cycloheximide | multiple interactions | EXP | | 6480464 | [Cycloheximide co-treated with FASLG protein] results in decreased expression of DNMT3A mRNA; more ... | CTD | PMID:19833194 |
| cyclophosphamide | multiple interactions | ISO | RGD:1606342 | 6480464 | [Cyclophosphamide co-treated with NAc-Sar-Gly-Val-(d-allo-Ile)-Thr-Nva-Ile-Arg-ProNEt] results in increased expression of FASLG | CTD | PMID:16166447 |
| cyclosporin A | decreases expression | ISO | RGD:1606342 | 6480464 | Cyclosporine results in decreased expression of FASLG protein | CTD | PMID:9247148 |
| cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of FASLG mRNA | CTD | PMID:10617104 |
| cyclosporin A | multiple interactions | EXP | | 6480464 | Cyclosporine inhibits the reaction [Doxorubicin results in increased expression of FASLG mRNA]; more ... | CTD | PMID:15799720 |
| cyclosporin A | decreases secretion | ISO | RGD:1606342 | 6480464 | Cyclosporine results in decreased secretion of FASLG protein | CTD | PMID:11692113 |
| daunorubicin | multiple interactions | EXP | | 6480464 | candesartan inhibits the reaction [Daunorubicin results in increased expression of FASLG protein] | CTD | PMID:16324756 |
| daunorubicin | increases expression | EXP | | 6480464 | Daunorubicin results in increased expression of FASLG protein | CTD | PMID:16324756 |
| DDE | increases expression | EXP | | 6480464 | Dichlorodiphenyl Dichloroethylene results in increased expression of FASLG mRNA | CTD | PMID:20025943 |
| DDE | increases expression | EXP | | 6480464 | Dichlorodiphenyl Dichloroethylene results in increased expression of FASLG mRNA | CTD | PMID:20025943 PMID:21384494 |
| dexamethasone | decreases expression | ISO | RGD:1606342 | 6480464 | Dexamethasone results in decreased expression of FASLG protein | CTD | PMID:9528991 |
| dexamethasone | decreases expression | EXP | | 6480464 | Dexamethasone results in decreased expression of FASLG mRNA; more ... | CTD | PMID:11778176 |
| dexamethasone | decreases secretion | ISO | RGD:1606342 | 6480464 | Dexamethasone results in decreased secretion of FASLG protein | CTD | PMID:11692113 |
| diarsenic trioxide | increases expression | ISO | RGD:1606342 | 6480464 | arsenic trioxide results in increased expression of FASL protein | CTD | PMID:20819644 |
| diarsenic trioxide | increases expression | ISO | RGD:1606342 | 6480464 | arsenic trioxide results in increased expression of FASLG | CTD | PMID:12975549 |
| diarsenic trioxide | increases expression | ISO | RGD:1606342 | 6480464 | arsenic trioxide results in increased expression of FASLG protein | CTD | PMID:12684647 |
| diarsenic trioxide | multiple interactions | ISO | RGD:1606342 | 6480464 | bortezomib promotes the reaction [arsenic trioxide results in increased activity of FASLG] | CTD | PMID:20471514 |
| diarsenic trioxide | increases expression | ISO | RGD:1606342 | 6480464 | arsenic trioxide results in increased expression of FASLG mRNA | CTD | PMID:17530438 |
| diarsenic trioxide | multiple interactions | ISO | RGD:1606342 | 6480464 | arsenic trioxide promotes the reaction [puerarin results in increased expression of FASLG protein] | CTD | PMID:20416161 |
| diazoxide | increases expression | EXP | | 6480464 | Isoproterenol results in increased expression of FASLG protein | CTD | PMID:19001025 |
| dichlorvos | decreases expression | ISO | RGD:1553064 | 6480464 | Dichlorvos results in decreased expression of FASL protein | CTD | PMID:15369847 |
| diclofenac | increases expression | ISO | RGD:1553064 | 6480464 | Diclofenac results in increased expression of FASL mRNA | CTD | PMID:22285467 |
| diethylstilbestrol | increases expression | ISO | RGD:1553064 | 6480464 | Diethylstilbestrol results in increased expression of FASL mRNA | CTD | PMID:16510352 PMID:15545218 |
| diethylstilbestrol | increases expression | ISO | RGD:1553064 | 6480464 | Diethylstilbestrol results in increased expression of FASL mRNA | CTD | PMID:15545218 PMID:16510352 |
| diethylstilbestrol | multiple interactions | EXP | | 6480464 | Testosterone inhibits the reaction [Diethylstilbestrol results in increased expression of FASLG protein] | CTD | PMID:12477725 |
| diethylstilbestrol | increases expression | EXP | | 6480464 | Diethylstilbestrol results in increased expression of FASLG protein | CTD | PMID:12477725 |
| dimethyl sulfoxide | decreases expression | EXP | | 6480464 | Dimethyl Sulfoxide results in decreased expression of FASLG mRNA | CTD | PMID:10925121 |
| dimethylarsinic acid | increases expression | EXP | | 6480464 | Cacodylic Acid results in increased expression of FASLG mRNA | CTD | PMID:17481689 |
| dimethylarsinic acid | decreases expression | ISO | RGD:1553064 | 6480464 | Cacodylic Acid results in decreased expression of FASL mRNA | CTD | PMID:15345372 |
| doxazosin | increases expression | ISO | RGD:1606342 | 6480464 | Doxazosin results in increased expression of FASLG mRNA | CTD | PMID:12771931 |
| doxorubicin | multiple interactions | EXP | | 6480464 | [diphenyleneiodonium co-treated with mitoquinol co-treated with mitoquinone] inhibits the reaction [Doxorubicin results in increased expression of FASL protein]; more ... | CTD | PMID:15799720 |
| doxorubicin | increases expression | ISO | RGD:1606342 | 6480464 | Doxorubicin results in increased expression of FASLG mRNA | CTD | PMID:17088865 PMID:15763944 |
| doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of FASLG protein | CTD | PMID:15799720 PMID:15315341 |
| doxorubicin | increases secretion | EXP | | 6480464 | Doxorubicin results in increased secretion of FASLG protein | CTD | PMID:15703961 |
| doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of FASLG protein | CTD | PMID:15315341 PMID:15799720 |
| doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of FASLG mRNA | CTD | PMID:15799720 |
| doxorubicin | multiple interactions | EXP | | 6480464 | benazepril inhibits the reaction [Doxorubicin results in increased expression of FASLG protein]; more ... | CTD | PMID:15315341 |
| doxorubicin | multiple interactions | ISO | RGD:1606342 | 6480464 | Lovastatin inhibits the reaction [Doxorubicin results in increased expression of FASLG mRNA] | CTD | PMID:17088865 |
| doxorubicin | multiple interactions | ISO | RGD:1553064 | 6480464 | [THBS1 protein alternative form co-treated with Doxorubicin] results in increased expression of FASLG protein | CTD | PMID:15818399 |
| doxorubicin | multiple interactions | ISO | RGD:1606342 | 6480464 | [FAS protein co-treated with FASLG protein] results in increased susceptibility to Doxorubicin | CTD | PMID:15981920 |
| doxorubicin | increases expression | ISO | RGD:1606342 | 6480464 | Doxorubicin results in increased expression of FASLG mRNA | CTD | PMID:15763944 PMID:17088865 |
| doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of FASL protein | CTD | PMID:12107157 |
| doxorubicin | multiple interactions | ISO | RGD:1606342 | 6480464 | ANGPT1 protein inhibits the reaction [Doxorubicin results in increased expression of FASLG mRNA] | CTD | PMID:15763944 |
| enalapril | decreases expression | EXP | | 6480464 | Enalapril results in decreased expression of FASLG mRNA | CTD | PMID:10925121 |
| esculetin | multiple interactions | ISO | RGD:1606342 | 6480464 | [esculetin co-treated with Paclitaxel] results in increased expression of FASLG protein | CTD | PMID:16051289 |
| etoposide | multiple interactions | ISO | RGD:1606342 | 6480464 | [3-morpholino-sydnonimine results in increased abundance of Nitric Oxide] inhibits the reaction [Etoposide results in increased activity of FASLG promoter]; more ... | CTD | PMID:10811113 |
| etoposide | increases activity | ISO | RGD:1606342 | 6480464 | Etoposide results in increased activity of FASLG promoter | CTD | PMID:10811113 |
| fisetin | multiple interactions | ISO | RGD:1606342 | 6480464 | [Cisplatin co-treated with fisetin] results in increased expression of FASLG protein | CTD | PMID:21216935 |
| fisetin | increases expression | ISO | RGD:1606342 | 6480464 | fisetin results in increased expression of FASLG protein | CTD | PMID:21216935 |
| flavanone | increases expression | ISO | RGD:1606342 | 6480464 | flavanone results in increased expression of FASLG mRNA | CTD | PMID:22056764 |
| flutamide | decreases expression | EXP | | 6480464 | Flutamide results in decreased expression of FASLG protein | CTD | PMID:20850791 |
| formaldehyde | increases expression | EXP | | 6480464 | Formaldehyde results in increased expression of FASLG mRNA | CTD | PMID:12679049 |
| fulvestrant | decreases expression | ISO | RGD:1606342 | 6480464 | fulvestrant results in decreased expression of FASLG mRNA | CTD | PMID:20145137 |
| fulvestrant | increases expression | ISO | RGD:1606342 | 6480464 | [fulvestrant results in increased expression of TGFB1 protein] which results in increased expression of FASLG mRNA | CTD | PMID:20145137 |
| furan | increases expression | EXP | | 6480464 | furan results in increased expression of FASLG mRNA | CTD | PMID:22079235 |
| furosemide | affects expression | EXP | | 6480464 | Furosemide affects the expression of FASLG mRNA | CTD | PMID:17497460 |
| gallic acid | increases expression | ISO | RGD:1606342 | 6480464 | Gallic Acid results in increased expression of FASLG protein | CTD | PMID:22245431 |
| gamma-hexachlorocyclohexane | increases expression | EXP | | 6480464 | Lindane results in increased expression of FASLG protein | CTD | PMID:19038305 |
| glutathione | decreases abundance | ISO | RGD:1606342 | 6480464 | FASL protein results in decreased abundance of Glutathione | CTD | PMID:17724027 |
| glutathione | multiple interactions | ISO | RGD:1606342 | 6480464 | verlukast promotes the reaction [FASL protein results in decreased abundance of Glutathione] | CTD | PMID:17724027 |
| hexachlorobenzene | increases expression | EXP | | 6480464 | Hexachlorobenzene results in increased expression of FASLG protein | CTD | PMID:21787832 |
| hydrogen peroxide | increases chemical synthesis | ISO | RGD:1606342 | 6480464 | FASL protein results in increased chemical synthesis of Hydrogen Peroxide | CTD | PMID:17724027 |
| hydrogen peroxide | increases expression | ISO | RGD:1606342 | 6480464 | Hydrogen Peroxide results in increased expression of FASLG mRNA | CTD | PMID:21347231 |
| hydrogen peroxide | increases expression | EXP | | 6480464 | Hydrogen Peroxide results in increased expression of FASLG protein | CTD | PMID:15799720 |
| hydrogen peroxide | multiple interactions | ISO | RGD:1606342 | 6480464 | [Clozapine analog co-treated with Hydrogen Peroxide] results in increased expression of FASLG mRNA; more ... | CTD | PMID:16510162 |
| hydrogen peroxide | multiple interactions | EXP | | 6480464 | [mitoquinol co-treated with mitoquinone] inhibits the reaction [Hydrogen Peroxide results in increased expression of FASL protein]; more ... | CTD | PMID:15799720 |
| hydrogen peroxide | multiple interactions | ISO | RGD:1606342 | 6480464 | Pyruvic Acid inhibits the reaction [FASL protein results in increased chemical synthesis of Hydrogen Peroxide] | CTD | PMID:17724027 |
| hydroquinone O-beta-D-glucopyranoside | decreases expression | ISO | RGD:1606342 | 6480464 | Arbutin results in decreased expression of FASLG mRNA | CTD | PMID:17103032 |
| hydroxyurea | increases expression | ISO | RGD:1553064 | 6480464 | Hydroxyurea results in increased expression of FASL mRNA | CTD | PMID:16356682 |
| ifosfamide | increases expression | ISO | RGD:1606342 | 6480464 | Ifosfamide results in increased expression of FASL | CTD | PMID:16453328 |
| indomethacin | multiple interactions | EXP | | 6480464 | lansoprazole inhibits the reaction [Indomethacin results in increased expression of FASLG mRNA] | CTD | PMID:18375387 |
| indomethacin | increases expression | EXP | | 6480464 | Indomethacin results in increased expression of FASLG mRNA | CTD | PMID:18375387 |
| inosine | increases expression | ISO | RGD:1606342 | 6480464 | Inosine results in increased expression of FASLG protein | CTD | PMID:16419169 |
| ionomycin | multiple interactions | ISO | RGD:1606342 | 6480464 | [Tetradecanoylphorbol Acetate co-treated with Ionomycin co-treated with Estradiol] results in decreased expression of FASLG mRNA; more ... | CTD | PMID:20529085 |
| isoflurane | decreases expression | EXP | | 6480464 | Isoflurane results in decreased expression of FASLG mRNA | CTD | PMID:16978161 |
| isoprenaline | increases expression | EXP | | 6480464 | Isoproterenol results in increased expression of FASLG protein | CTD | PMID:19001025 |
| L-methionine | multiple interactions | ISO | RGD:1553064 | 6480464 | Methionine inhibits the reaction [Acetaminophen results in increased expression of FASL mRNA] | CTD | PMID:19739265 |
| lansoprazole | multiple interactions | EXP | | 6480464 | lansoprazole inhibits the reaction [Indomethacin results in increased expression of FASLG mRNA] | CTD | PMID:18375387 |
| lenalidomide | multiple interactions | ISO | RGD:1553064 | 6480464 | lenalidomide inhibits the reaction [SOD1 gene mutant form results in increased expression of FASL mRNA] | CTD | PMID:16510725 |
| losartan | decreases expression | EXP | | 6480464 | Losartan results in decreased expression of FASLG mRNA | CTD | PMID:10925121 |
| lovastatin | multiple interactions | ISO | RGD:1606342 | 6480464 | Lovastatin inhibits the reaction [Doxorubicin results in increased expression of FASLG mRNA] | CTD | PMID:17088865 |
| lycopene | decreases expression | ISO | RGD:1606342 | 6480464 | lycopene results in decreased expression of FASLG mRNA | CTD | PMID:16886892 |
| medroxyprogesterone acetate | multiple interactions | ISO | RGD:1606342 | 6480464 | [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of FASLG protein | CTD | PMID:16709600 |
| melatonin | multiple interactions | EXP | | 6480464 | Melatonin inhibits the reaction [Puromycin Aminonucleoside results in increased expression of FASLG protein] | CTD | PMID:14993511 |
| methamphetamine | increases expression | EXP | | 6480464 | Methamphetamine results in increased expression of FASLG mRNA; more ... | CTD | PMID:15644446 |
| methoxychlor | increases expression | EXP | | 6480464 | Methoxychlor results in increased expression of FASLG protein | CTD | PMID:20227399 |
| methylarsonic acid | increases expression | EXP | | 6480464 | monomethylarsonic acid results in increased expression of FASLG mRNA | CTD | PMID:17481689 |
| mifepristone | multiple interactions | ISO | RGD:1606342 | 6480464 | Mifepristone inhibits the reaction [Rifampin inhibits the reaction [FAS protein results in increased expression of FASLG protein]] | CTD | PMID:12645856 |
| mifepristone | increases expression | ISO | RGD:1606342 | 6480464 | Mifepristone results in increased expression of FASLG mRNA | CTD | PMID:16009178 |
| mitomycin C | increases expression | ISO | RGD:1606342 | 6480464 | Mitomycin results in increased expression of FASLG | CTD | PMID:16019139 |
| mitomycin C | increases expression | ISO | RGD:1606342 | 6480464 | Mitomycin results in increased expression of FASLG protein | CTD | PMID:16186332 PMID:16957513 |
| mitomycin C | increases expression | ISO | RGD:1606342 | 6480464 | Mitomycin results in increased expression of FASLG protein | CTD | PMID:16957513 PMID:16186332 |
| mitomycin C | increases expression | ISO | RGD:1606342 | 6480464 | Mitomycin results in increased expression of FASLG mRNA | CTD | PMID:16957513 |
| mono(2-ethylhexyl) phthalate | affects response to substance | ISO | RGD:1553064 | 6480464 | FASL affects the susceptibility to mono-(2-ethylhexyl)phthalate | CTD | PMID:20100735 |
| mono(2-ethylhexyl) phthalate | multiple interactions | ISO | RGD:1553064 | 6480464 | [FASL affects the susceptibility to mono-(2-ethylhexyl)phthalate] which affects the expression of CFLAR protein | CTD | PMID:20100735 |
| monocrotaline | multiple interactions | ISO | RGD:1553064 | 6480464 | [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of FASL mRNA | CTD | PMID:21224054 |
| morphine | multiple interactions | ISO | RGD:1553064 | 6480464 | [FAS protein binds to FASL protein] affects the reaction [Morphine results in increased expression of IL4 protein] | CTD | PMID:16210602 |
| morphine | increases expression | ISO | RGD:1553064 | 6480464 | Morphine results in increased expression of FASL mRNA | CTD | PMID:16210602 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:1606342 | 6480464 | Acetylcysteine inhibits the reaction [[Cisplatin co-treated with FASLG protein] results in increased activity of CASP8 protein]; more ... | CTD | PMID:17574045 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [beta-hexachlorocyclohexane results in increased expression of FASLG protein] | CTD | PMID:19760616 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | [atorvastatin co-treated with Acetylcysteine] inhibits the reaction [sodium arsenite results in increased expression of FASLG protein] | CTD | PMID:20946910 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:1606342 | 6480464 | Acetylcysteine inhibits the reaction [Arachidonic Acid results in increased expression of FASLG protein] | CTD | PMID:19720122 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:1606342 | 6480464 | [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] which results in decreased expression of FASLG mRNA | CTD | PMID:22429591 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:1553064 | 6480464 | Acetylcysteine inhibits the reaction [Zinc results in increased expression of FASLG protein] | CTD | PMID:11864783 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:1553064 | 6480464 | Acetylcysteine inhibits the reaction [Azoxymethane results in increased expression of FASLG protein] | CTD | PMID:20431929 |
| N-nitrosodiethylamine | decreases expression | EXP | | 6480464 | Diethylnitrosamine results in decreased expression of FASL mRNA | CTD | PMID:19427195 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | thiosalicylic acid inhibits the reaction [Diethylnitrosamine results in decreased expression of FASL mRNA] | CTD | PMID:19427195 |
| NADP zwitterion | multiple interactions | ISO | RGD:1553064 | 6480464 | CD38 gene mutant form inhibits the reaction [NADP promotes the reaction [FASL protein results in increased abundance of NAADP]]; more ... | CTD | PMID:20200208 |
| NADP(+) | multiple interactions | ISO | RGD:1553064 | 6480464 | CD38 gene mutant form inhibits the reaction [NADP promotes the reaction [FASL protein results in increased abundance of NAADP]]; more ... | CTD | PMID:20200208 |
| naproxen | multiple interactions | EXP | | 6480464 | [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of FASLG protein]; more ... | CTD | PMID:22150557 |
| nicotinamide | multiple interactions | ISO | RGD:1553064 | 6480464 | CD38 gene mutant form promotes the reaction [Niacinamide inhibits the reaction [NADP promotes the reaction [FASL protein results in increased abundance of NAADP]]] | CTD | PMID:20200208 |
| nitric oxide | multiple interactions | ISO | RGD:1606342 | 6480464 | [3-morpholino-sydnonimine results in increased abundance of Nitric Oxide] inhibits the reaction [Etoposide results in increased activity of FASLG promoter]; more ... | CTD | PMID:10811113 |
| nitrobenzene | affects response to substance | ISO | RGD:1553064 | 6480464 | FASL protein affects the susceptibility to nitrobenzene | CTD | PMID:12595153 |
| nocodazole | multiple interactions | ISO | RGD:1606342 | 6480464 | [TYMP co-treated with Nocodazole] results in decreased expression of FASLG mRNA; more ... | CTD | PMID:15907805 |
| ochratoxin A | increases expression | EXP | | 6480464 | ochratoxin A results in increased expression of FASLG mRNA | CTD | PMID:19562491 |
| ozone | increases expression | ISO | RGD:1553064 | 6480464 | Ozone results in increased expression of FASL mRNA; more ... | CTD | PMID:18315731 |
| paclitaxel | multiple interactions | ISO | RGD:1606342 | 6480464 | [esculetin co-treated with Paclitaxel] results in increased expression of FASLG protein | CTD | PMID:16051289 |
| paclitaxel | increases expression | ISO | RGD:1606342 | 6480464 | Paclitaxel results in increased expression of FASLG protein | CTD | PMID:10502406 more ... |
| paclitaxel | increases expression | ISO | RGD:1606342 | 6480464 | Paclitaxel results in increased expression of FASLG protein | CTD | PMID:15907805 more ... |
| paclitaxel | increases expression | ISO | RGD:1606342 | 6480464 | Paclitaxel results in increased expression of FASLG protein | CTD | PMID:18074150 more ... |
| paclitaxel | increases expression | ISO | RGD:1606342 | 6480464 | Paclitaxel results in increased expression of FASLG protein | CTD | PMID:18074150 more ... |
| paclitaxel | increases expression | ISO | RGD:1606342 | 6480464 | Paclitaxel results in increased expression of FASLG protein | CTD | PMID:10502406 more ... |
| paclitaxel | increases expression | ISO | RGD:1606342 | 6480464 | Paclitaxel results in increased expression of FASLG mRNA | CTD | PMID:15907805 |
| paclitaxel | increases expression | ISO | RGD:1606342 | 6480464 | Paclitaxel results in increased expression of FASLG protein | CTD | PMID:11716366 more ... |
| paclitaxel | increases response to substance | ISO | RGD:1606342 | 6480464 | FASLG protein results in increased susceptibility to Paclitaxel | CTD | PMID:18074150 |
| paclitaxel | multiple interactions | ISO | RGD:1606342 | 6480464 | TYMP inhibits the reaction [Paclitaxel results in increased expression of FASLG mRNA]; more ... | CTD | PMID:15907805 |
| paracetamol | increases expression | ISO | RGD:1553064 | 6480464 | Acetaminophen results in increased expression of FASL mRNA | CTD | PMID:12540782 more ... |
| paracetamol | increases expression | ISO | RGD:1553064 | 6480464 | Acetaminophen results in increased expression of FASL mRNA | CTD | PMID:19739265 more ... |
| paracetamol | multiple interactions | ISO | RGD:1553064 | 6480464 | manumycin inhibits the reaction [Acetaminophen results in increased expression of FASL mRNA]; more ... | CTD | PMID:19739265 |
| paracetamol | multiple interactions | ISO | RGD:1553064 | 6480464 | KLRB1C protein promotes the reaction [Acetaminophen results in increased expression of FASL mRNA] | CTD | PMID:15578514 |
| paracetamol | multiple interactions | ISO | RGD:1553064 | 6480464 | O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate inhibits the reaction [Acetaminophen results in increased expression of FASL mRNA]; more ... | CTD | PMID:12540782 |
| paracetamol | increases expression | ISO | RGD:1553064 | 6480464 | Acetaminophen results in increased expression of FASL protein | CTD | PMID:12540782 |
| paracetamol | increases response to substance | ISO | RGD:1553064 | 6480464 | FASL protein results in increased susceptibility to Acetaminophen | CTD | PMID:15578514 |
| paracetamol | increases expression | ISO | RGD:1553064 | 6480464 | Acetaminophen results in increased expression of FASL mRNA | CTD | PMID:12540782 more ... |
| paraquat | increases expression | ISO | RGD:1553064 | 6480464 | Paraquat results in increased expression of FASL mRNA | CTD | PMID:17215068 |
| pentobarbital | decreases expression | EXP | | 6480464 | Pentobarbital results in decreased expression of FASLG mRNA | CTD | PMID:16978161 |
| phenobarbital | affects expression | ISO | RGD:1606342 | 6480464 | Phenobarbital affects the expression of FASLG mRNA | CTD | PMID:19084549 |
| phenytoin | multiple interactions | ISO | RGD:1553064 | 6480464 | [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of FASL mRNA | CTD | PMID:21224054 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1606342 | 6480464 | Tamoxifen inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin co-treated with Estradiol] results in decreased expression of FASLG mRNA]; more ... | CTD | PMID:20529085 |
| phylloquinone | multiple interactions | ISO | RGD:1606342 | 6480464 | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [[sorafenib co-treated with Vitamin K 1] results in increased expression of FASLG protein] | CTD | PMID:20301194 |
| prostaglandin E2 | increases expression | ISO | RGD:1553064 | 6480464 | Dinoprostone results in increased expression of FASLG | CTD | PMID:15491851 |
| prostaglandin E2 | increases response to substance | ISO | RGD:1553064 | 6480464 | FASLG results in increased susceptibility to Dinoprostone | CTD | PMID:15491851 |
| pterostilbene | increases expression | ISO | RGD:1553064 | 6480464 | pterostilbene results in increased expression of FASL protein | CTD | PMID:20681671 |
| pyruvic acid | multiple interactions | ISO | RGD:1606342 | 6480464 | Pyruvic Acid inhibits the reaction [FASL protein results in increased chemical synthesis of Hydrogen Peroxide] | CTD | PMID:17724027 |
| quercetin | decreases expression | EXP | | 6480464 | Quercetin results in decreased expression of FASLG mRNA | CTD | PMID:10925121 |
| resveratrol | increases expression | ISO | RGD:1606342 | 6480464 | resveratrol results in increased expression of FASLG protein | CTD | PMID:15217905 more ... |
| resveratrol | increases expression | ISO | RGD:1606342 | 6480464 | resveratrol results in increased expression of FASLG protein | CTD | PMID:15217905 |
| resveratrol | multiple interactions | ISO | RGD:1606342 | 6480464 | resveratrol promotes the reaction [FOXO3 protein binds to FASLG promoter] | CTD | PMID:17513867 |
| resveratrol | increases expression | ISO | RGD:1553064 | 6480464 | resveratrol results in increased expression of FASL protein | CTD | PMID:17872969 |
| resveratrol | increases expression | ISO | RGD:1606342 | 6480464 | resveratrol results in increased expression of FASLG mRNA | CTD | PMID:20717957 PMID:9680369 |
| rifampicin | multiple interactions | ISO | RGD:1553064 | 6480464 | [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of FASL mRNA | CTD | PMID:21224054 |
| rifampicin | decreases expression | ISO | RGD:1606342 | 6480464 | Rifampin results in decreased expression of FASLG mRNA; more ... | CTD | PMID:11958592 |
| rifampicin | multiple interactions | ISO | RGD:1606342 | 6480464 | Mifepristone inhibits the reaction [Rifampin inhibits the reaction [FAS protein results in increased expression of FASLG protein]] | CTD | PMID:12645856 |
| rosiglitazone | multiple interactions | EXP | | 6480464 | rosiglitazone inhibits the reaction [Streptozocin results in increased expression of FASLG mRNA] | CTD | PMID:21791967 |
| ryanodine | multiple interactions | ISO | RGD:1553064 | 6480464 | Ryanodine inhibits the reaction [FASL protein affects the localization of Calcium] | CTD | PMID:20200208 |
| S-nitrosoglutathione | multiple interactions | ISO | RGD:1606342 | 6480464 | [S-Nitrosoglutathione results in increased abundance of Nitric Oxide] inhibits the reaction [N-caproylsphingosine results in increased activity of FASLG promoter]; more ... | CTD | PMID:10811113 |
| Se-methyl-L-selenocysteine | multiple interactions | ISO | RGD:1606342 | 6480464 | [selenomethylselenocysteine co-treated with irinotecan] results in increased expression of FASLG | CTD | PMID:15897249 |
| Se-methylselenocysteine | multiple interactions | ISO | RGD:1606342 | 6480464 | [selenomethylselenocysteine co-treated with irinotecan] results in increased expression of FASLG | CTD | PMID:15897249 |
| sirolimus | decreases secretion | ISO | RGD:1606342 | 6480464 | Sirolimus results in decreased secretion of FASLG protein | CTD | PMID:11692113 |
| sodium fluoride | increases expression | ISO | RGD:1606342 | 6480464 | Sodium Fluoride results in increased expression of FASLG mRNA | CTD | PMID:19852076 |
| streptozocin | multiple interactions | EXP | | 6480464 | rosiglitazone inhibits the reaction [Streptozocin results in increased expression of FASLG mRNA] | CTD | PMID:21791967 |
| streptozocin | increases expression | EXP | | 6480464 | Streptozocin results in increased expression of FASLG mRNA | CTD | PMID:21791967 |
| sumatriptan | multiple interactions | EXP | | 6480464 | Sumatriptan inhibits the reaction [Capsaicin results in increased expression of FASLG protein]; more ... | CTD | PMID:22150557 |
| tacrolimus hydrate | decreases secretion | ISO | RGD:1606342 | 6480464 | Tacrolimus results in decreased secretion of FASLG protein | CTD | PMID:11692113 |
| tamoxifen | multiple interactions | EXP | | 6480464 | [BCL2 co-treated with Tamoxifen] results in increased expression of FASL protein | CTD | PMID:15606891 |
| tamoxifen | increases expression | ISO | RGD:1606342 | 6480464 | [Tamoxifen results in increased expression of TGFB1 protein] which results in increased expression of FASLG mRNA | CTD | PMID:20145137 |
| tamoxifen | increases expression | ISO | RGD:1606342 | 6480464 | Tamoxifen results in increased expression of FASLG protein | CTD | PMID:12721755 |
| tamoxifen | decreases expression | ISO | RGD:1606342 | 6480464 | Tamoxifen results in decreased expression of FASLG mRNA | CTD | PMID:20145137 |
| tamoxifen | increases expression | ISO | RGD:1553064 | 6480464 | Tamoxifen results in increased expression of FASL protein | CTD | PMID:12721755 |
| tamoxifen | multiple interactions | ISO | RGD:1606342 | 6480464 | Tamoxifen inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin co-treated with Estradiol] results in decreased expression of FASLG mRNA] | CTD | PMID:20529085 |
| telmisartan | multiple interactions | ISO | RGD:1553064 | 6480464 | telmisartan inhibits the reaction [Cadmium Chloride results in increased expression of FASL protein] | CTD | PMID:21620867 |
| telmisartan | multiple interactions | EXP | | 6480464 | telmisartan inhibits the reaction [Cadmium Chloride results in increased expression of FASLG protein] | CTD | PMID:21819444 |
| testosterone | multiple interactions | ISO | RGD:1606342 | 6480464 | [Tetradecanoylphorbol Acetate co-treated with Ionomycin co-treated with Testosterone] results in increased expression of FASLG mRNA; more ... | CTD | PMID:20529085 |
| testosterone | multiple interactions | EXP | | 6480464 | Testosterone inhibits the reaction [Diethylstilbestrol results in increased expression of FASLG protein] | CTD | PMID:12477725 |
| testosterone | decreases expression | EXP | | 6480464 | Testosterone deficiency results in decreased expression of FASLG protein | CTD | PMID:20850791 |
| tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of FASLG mRNA | CTD | PMID:17105443 more ... |
| tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of FASLG mRNA | CTD | PMID:16609999 more ... |
| tetrachloromethane | increases expression | ISO | RGD:1553064 | 6480464 | Carbon Tetrachloride results in increased expression of FASL protein | CTD | PMID:18436364 PMID:18291569 |
| tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of FASLG mRNA | CTD | PMID:16644059 more ... |
| tetrachloromethane | multiple interactions | EXP | | 6480464 | IL10 protein promotes the reaction [Carbon Tetrachloride results in increased expression of FASLG mRNA] | CTD | PMID:16609999 PMID:17105443 |
| tetrachloromethane | multiple interactions | EXP | | 6480464 | IL10 protein promotes the reaction [Carbon Tetrachloride results in increased expression of FASLG mRNA] | CTD | PMID:17105443 PMID:16609999 |
| tetrachloromethane | multiple interactions | EXP | | 6480464 | IL10 protein promotes the reaction [Carbon Tetrachloride results in increased expression of FASLG protein] | CTD | PMID:17105443 |
| tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of FASLG protein | CTD | PMID:17105443 |
| tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of FASLG mRNA | CTD | PMID:16644059 more ... |
| tetrachloromethane | increases expression | ISO | RGD:1553064 | 6480464 | Carbon Tetrachloride results in increased expression of FASL protein | CTD | PMID:18291569 PMID:18436364 |
| tetrachloromethane | multiple interactions | ISO | RGD:1553064 | 6480464 | phenyl caffeate inhibits the reaction [Carbon Tetrachloride results in increased expression of FASL protein] | CTD | PMID:18436364 |
| tetrachloromethane | multiple interactions | ISO | RGD:1553064 | 6480464 | Changkil inhibits the reaction [Carbon Tetrachloride results in increased expression of FASL protein] | CTD | PMID:18291569 |
| thalidomide | multiple interactions | ISO | RGD:1553064 | 6480464 | Thalidomide inhibits the reaction [SOD1 gene mutant form results in increased expression of FASL mRNA] | CTD | PMID:16510725 |
| thalidomide | decreases expression | ISO | RGD:1606342 | 6480464 | Thalidomide results in decreased expression of FASLG protein | CTD | PMID:16531263 |
| thymidine | increases expression | ISO | RGD:1606342 | 6480464 | Thymidine results in increased expression of FASLG protein | CTD | PMID:16419169 |
| trans-resveratrol | increases expression | ISO | RGD:1606342 | 6480464 | resveratrol results in increased expression of FASLG protein | CTD | PMID:15217905 more ... |
| trans-resveratrol | increases expression | ISO | RGD:1606342 | 6480464 | resveratrol results in increased expression of FASLG protein | CTD | PMID:15217905 |
| trans-resveratrol | multiple interactions | ISO | RGD:1606342 | 6480464 | resveratrol promotes the reaction [FOXO3 protein binds to FASLG promoter] | CTD | PMID:17513867 |
| trans-resveratrol | increases expression | ISO | RGD:1553064 | 6480464 | resveratrol results in increased expression of FASL protein | CTD | PMID:17872969 |
| trans-resveratrol | increases expression | ISO | RGD:1606342 | 6480464 | resveratrol results in increased expression of FASLG mRNA | CTD | PMID:20717957 PMID:9680369 |
| trimethylarsine oxide | increases expression | EXP | | 6480464 | trimethylarsine oxide results in increased expression of FASLG mRNA | CTD | PMID:17481689 |
| troglitazone | increases expression | ISO | RGD:1606342 | 6480464 | troglitazone results in increased expression of FASLG mRNA | CTD | PMID:19631733 |
| uranium atom | increases expression | EXP | | 6480464 | Uranium results in increased expression of FASLG mRNA | CTD | PMID:16854789 |
| uridine | increases expression | ISO | RGD:1606342 | 6480464 | Uridine results in increased expression of FASLG protein | CTD | PMID:16419169 |
| valsartan | multiple interactions | EXP | | 6480464 | benazepril promotes the reaction [valsartan inhibits the reaction [Doxorubicin results in increased expression of FASLG protein]]; more ... | CTD | PMID:15315341 |
| vincaleukoblastine | increases expression | ISO | RGD:1606342 | 6480464 | Vinblastine results in increased expression of FASLG protein | CTD | PMID:11716366 |
| vincristine | increases expression | ISO | RGD:1606342 | 6480464 | Vincristine results in increased expression of FASLG protein | CTD | PMID:11716366 |
| vinorelbine | multiple interactions | ISO | RGD:1553064 | 6480464 | [Cisplatin co-treated with vinorelbine] results in decreased expression of FASL mRNA | CTD | PMID:21544650 |
| wortmannin | multiple interactions | ISO | RGD:1606342 | 6480464 | wortmannin inhibits the reaction [evodiamine results in increased expression of FASLG protein] | CTD | PMID:20005289 |
| zidovudine | increases expression | ISO | RGD:1553064 | 6480464 | Zidovudine results in increased expression of FASLG protein | CTD | PMID:17943461 |
| zinc atom | increases expression | ISO | RGD:1606342 | 6480464 | Zinc results in increased expression of FASLG protein | CTD | PMID:16472982 |
| zinc atom | decreases expression | ISO | RGD:1606342 | 6480464 | Zinc deficiency results in decreased expression of FASLG mRNA | CTD | PMID:22171008 |
| zinc atom | increases expression | ISO | RGD:1553064 | 6480464 | Zinc results in increased expression of FASLG mRNA; more ... | CTD | PMID:11864783 |
| zinc atom | multiple interactions | ISO | RGD:1553064 | 6480464 | Acetylcysteine inhibits the reaction [Zinc results in increased expression of FASLG protein] | CTD | PMID:11864783 |
| zinc protoporphyrin | multiple interactions | ISO | RGD:1606342 | 6480464 | zinc protoporphyrin inhibits the reaction [FASLG protein results in increased activity of CASP3 protein]; more ... | CTD | PMID:16051694 |
| zinc(0) | increases expression | ISO | RGD:1606342 | 6480464 | Zinc results in increased expression of FASLG protein | CTD | PMID:16472982 |
| zinc(0) | decreases expression | ISO | RGD:1606342 | 6480464 | Zinc deficiency results in decreased expression of FASLG mRNA | CTD | PMID:22171008 |
| zinc(0) | multiple interactions | ISO | RGD:1553064 | 6480464 | Acetylcysteine inhibits the reaction [Zinc results in increased expression of FASLG protein] | CTD | PMID:11864783 |
| zinc(0) | increases expression | ISO | RGD:1553064 | 6480464 | Zinc results in increased expression of FASLG mRNA; more ... | CTD | PMID:11864783 |
| zoledronic acid | affects expression | ISO | RGD:1606342 | 6480464 | zoledronic acid affects the expression of FASLG mRNA | CTD | PMID:19036117 |